UPDATE: Needham & Company Downgrades Neogenomics (NEO) to Hold
Tweet Send to a Friend
(Updated - August 22, 2022 9:21 AM EDT)
Needham & Company analyst Mike Matson downgraded Neogenomics (NASDAQ: NEO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Needham & Company analyst Mike Matson downgraded Neogenomics (NASDAQ: NEO) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
